Business / Finance

RSS
Cameron Health announces completion of $107 million equity financing round

Cameron Health announces completion of $107 million equity financing round

Thermo Fisher Scientific acquires Sterilin

Thermo Fisher Scientific acquires Sterilin

Abiomed fiscal fourth quarter revenue increases 24% to $28.5 million

Abiomed fiscal fourth quarter revenue increases 24% to $28.5 million

Centene prices public offering of $250 million senior notes

Centene prices public offering of $250 million senior notes

Aeterna Zentaris first quarter revenues increase to $7.4 million

Aeterna Zentaris first quarter revenues increase to $7.4 million

Concord Medical first quarter total net revenues increase 14.7% to $13.3 million

Concord Medical first quarter total net revenues increase 14.7% to $13.3 million

Clinipace Worldwide announces acquisition of PFC

Clinipace Worldwide announces acquisition of PFC

Ampio's common stock to be listed on NASDAQ Capital Market

Ampio's common stock to be listed on NASDAQ Capital Market

Thermo Fisher Scientific acquires Dionex

Thermo Fisher Scientific acquires Dionex

Excaliber subsidiary merges with VistaGen

Excaliber subsidiary merges with VistaGen

CryoLife acquires Cardiogenesis

CryoLife acquires Cardiogenesis

Pernix first quarter net revenues increase 14% to $10.1 million

Pernix first quarter net revenues increase 14% to $10.1 million

HASCO Medical acquires Wheelchair Vans of America and Mobility Freedom

HASCO Medical acquires Wheelchair Vans of America and Mobility Freedom

LifeVantage fiscal third quarter net revenue increases 270% to $10.0 million

LifeVantage fiscal third quarter net revenue increases 270% to $10.0 million

Targacept proposes $75 million underwritten public offering of common stock

Targacept proposes $75 million underwritten public offering of common stock

Columbia Laboratories to be listed on NASDAQ Biotechnology Index

Columbia Laboratories to be listed on NASDAQ Biotechnology Index

American Heart Association recognizes NIC as Platinum-Level Start! Fit-Friendly Company

American Heart Association recognizes NIC as Platinum-Level Start! Fit-Friendly Company

Business trends shape medical practices

Business trends shape medical practices

Thermo Fisher Scientific announces completion of Dionex tender offer

Thermo Fisher Scientific announces completion of Dionex tender offer

CytRx sells global rights of molecular chaperone assets to Orphazyme

CytRx sells global rights of molecular chaperone assets to Orphazyme

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.